eXmoor Pharma will be attending BIO-Europe 2026 in Cologne, 9–11 November. Connect with Manuel Balbuena and Ruxandra Comisel to discuss process development, GMP manufacturing and your next stage of CGT development.
Oct 23, 2026
BIO-Europe 2026
BIO-Europe 2026
Date: 9–11 November 2026
Location: Koelnmesse, Cologne, Germany
BIO-Europe brings together biotech and pharma teams for three days of partnering and business development.
eXmoor Pharma will be attending as delegates this year, with Manuel Balbuena, Chief Commercial Officer, and Ruxandra Comisel, Business Development Manager, available for one-to-one meetings throughout the event.
Planning your next development or manufacturing step?
For cell and gene therapy developers, early decisions around process development, scale-up and GMP can have a direct impact on later clinical and commercial progress.
Our team can discuss:
- Process development and scale-up for cell therapies, viral vectors and RNA
- Analytical development and method transfer
- Technology transfer into GMP manufacturing
- GMP clinical manufacturing
- Preparation for later-phase and commercial supply
- CMC and manufacturing strategy where additional consultancy support is needed
Our focus is on helping developers build robust processes, reduce downstream risk and create a clearer route into GMP manufacturing.
Meet Manuel and Ruxandra at BIO-Europe
If you are attending BIO-Europe and would like to discuss an upcoming development or manufacturing requirement, arrange a meeting with Manuel or Ruxi through the partnering platform or connect with them on LinkedIn.
Let’s Accelerate Your Therapy Together
Whether you're in early-stage development or scaling up for commercial production, eXmoor Pharma provides the expertise and flexibility you need. Partner with us to move your therapy forward with confidence.